Pain Management / Sedation

FDA announces July 22-23 meeting to discuss extended-release and long-acting opioid analgesics

The U.S. Food and Drug Administration announced a joint meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting to discuss Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Read more at http://www.fda.gov/AdvisoryCommittees/Calendar/ucm214816.htm.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares